Robert Shepherd
Corporate Officer/Principal chez DIMERIX LIMITED
Profil
Robert Shepherd is currently the Chief Commercialisation Officer at Dimerix Ltd.
Prior to his current position, he worked as the Senior Development Manager at Medicines Development for Global Health Ltd from 2013 to 2017.
Dr. Shepherd holds a doctorate degree from Monash University, which was conferred in 2012.
He also obtained an undergraduate degree from Monash University in 2007.
Postes actifs de Robert Shepherd
| Sociétés | Poste | Début |
|---|---|---|
| DIMERIX LIMITED | Corporate Officer/Principal | - |
Anciens postes connus de Robert Shepherd
| Sociétés | Poste | Fin |
|---|---|---|
Medicines Development for Global Health Ltd
 Medicines Development for Global Health Ltd Pharmaceuticals: MajorHealth Technology Medicines Development Ltd. engages in the development of medicines and vaccines. Its development programs include Moxidectin Program, Global Health Programs, and Consulting ervices. The company was founded by Mark Sullivan in 2005 and is headquartered in Melbourne, Australia. | Corporate Officer/Principal | 01/03/2017 |
Formation de Robert Shepherd
| Monash University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DIMERIX LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
Medicines Development for Global Health Ltd
Medicines Development for Global Health Ltd Pharmaceuticals: MajorHealth Technology Medicines Development Ltd. engages in the development of medicines and vaccines. Its development programs include Moxidectin Program, Global Health Programs, and Consulting ervices. The company was founded by Mark Sullivan in 2005 and is headquartered in Melbourne, Australia. | Health Technology |
